Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseases
Srivicha Krudsood
The Southeast Asian journal of tropical medicine and public health, 2001
View PDFchevron_right
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria
Sanjeev Krishna
British Journal of Clinical Pharmacology, 1993
View PDFchevron_right
Halofantrine : a new substance for treatment of multidrug-resistant malaria
Ralf Clemens
The Clinical Investigator, 1993
View PDFchevron_right
A clinical trial with halofantrine on patients with falciparum malaria in Colombia
Ellen Boudreau
Bulletin of the World Health Organization, 1996
View PDFchevron_right
Efficacy of halofantrine in malaria
Prakash Gambhir
Indian pediatrics
View PDFchevron_right
Chloroquine-resistant falciparum malaria: Responsiveness to treatment with halofantrine
Davy Koech
Parasitology Today, 1989
View PDFchevron_right
The effectiveness of halofantrine for the treatment of acute malaria in adults in the Solomon Islands
Nathan Kere
Parasitology Today, 1989
View PDFchevron_right
Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand
Ellen Boudreau
Bulletin of the World Health Organization, 1988
View PDFchevron_right
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine
Chinedum P E A C E Babalola
European Journal of Clinical Pharmacology, 2008
View PDFchevron_right
Effect of a single oral dose of FansidarTM on the pharmacokinetics of halofantrine in healthy volunteers: a preliminary report
Francis Hombhanje
British Journal of Clinical Pharmacology, 2001
View PDFchevron_right
Halofantrine and primaquine for radical cure of malaria in Irian Jaya Indonesia
david fryauff
Annals of tropical …, 1997
View PDFchevron_right
Effect of a single oral dose of Fansidar on the pharmacokinetics of halofantrine in healthy volunteers: a preliminary report
Francis Hombhanje
British journal of clinical pharmacology, 2000
View PDFchevron_right
Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection
Philippe Jacques Marie F Reinert
European Journal of Pediatrics, 2004
View PDFchevron_right
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria
G. Kokwaro, Edward Kamau
British Journal of Clinical Pharmacology, 1995
View PDFchevron_right
In Vivo Comparative Evaluation of Effects of Artemeter-Lumefantrine, Sulphadoxine-Pyrimetamine and Halofantrine on G6PD Activities, Haemoglobin Concentration and Malaria Parasite Clearance Rate in Malaria Infected Adults
michael elom
Journal of Biology, Agriculture and Healthcare, 2013
View PDFchevron_right
Effects of Prior Administration of Amodiaquine on the Disposition of Halofantrine in Healthy Volunteers
Michael O Daniyan
Therapeutic Drug Monitoring, 2007
View PDFchevron_right
Effect of altered serum lipid concentrations on the IC50 of halofantrine against plasmodium falciparum
John Horton
Journal of Pharmaceutical Sciences, 1998
View PDFchevron_right
Mefloquine Effect on Disposition of Halofantrine in the Isolated Perfused Rat Liver
Mark Marino
Journal of Pharmacy and Pharmacology, 1996
View PDFchevron_right
Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria
Farkad Ezzet
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers
Chinedum P E A C E Babalola
Journal of Clinical Pharmacy and Therapeutics, 2009
View PDFchevron_right
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base
Martin Danis
Malaria journal, 2009
View PDFchevron_right
The comparative efficacy and tolerability of CGP 56697 (artemether+lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France
Olivier Bouchaud
1999
View PDFchevron_right
Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99–411, with long acting prescription antimalarials, lumefantrine and piperaquine
WAHAJUDDIN Wahajuddin
Scientific Reports, 2015
View PDFchevron_right
Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice
Phusi La
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Comparative cardiac effects of antimalarial drug halofantrine with or without concomitant administration of kolanut or fluconazole in healthy volunteers
Kayode Adedapo
African Health Sciences
View PDFchevron_right
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
Kasia Stepniewska, Rose McGready, Stephane Proux
Tropical Medicine & International Health, 2007
View PDFchevron_right
Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei -Infected Mice
Vanessa Carla Furtado Mosqueira
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Cardiac complications of halofantrine: a prospective study of 20 patients
Simon Szwandt
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995
View PDFchevron_right